Burkholderia gladioli - a predictor of poor outcome in cystic fibrosis patients who receive lung transplants? A case of locally invasive rhinosinusitis and persistent bacteremia in a 36-year-old lung transplant recipient with cystic fibrosis

Can Respir J. 2011 Jul-Aug;18(4):e64-5. doi: 10.1155/2011/304179.

Abstract

There have been very few reports describing postlung transplant outcomes in patients' infected⁄colonized with Burkholderia gladioli pretransplant. A case involving a lung transplant recipient with cystic fibrosis who ultimately died as a result of severe rhinosinusitis due to B gladioli infection in the context of postlung transplant immunosuppression is reported.

Après une greffe pulmonaire, très peu de rapports décrivent les issues des patients qui étaient infectés ou colonisés par le Burkholderia gladioli avant la greffe. Est exposé le cas d’un greffé des poumons atteint de fibrose kystique qui est finalement décédé à cause d’une grave rhinosinusite causée par une infection à B gladioli dans le contexte de l’immunosuppression après la greffe pulmonaire.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anti-Bacterial Agents / therapeutic use
  • Bacteremia* / etiology
  • Burkholderia Infections / complications
  • Burkholderia Infections / microbiology
  • Burkholderia Infections / therapy*
  • Burkholderia gladioli*
  • Cystic Fibrosis / complications
  • Cystic Fibrosis / surgery*
  • Fatal Outcome
  • Female
  • Humans
  • Immunosuppression Therapy / adverse effects
  • Lung Transplantation* / immunology
  • Methicillin-Resistant Staphylococcus aureus
  • Opportunistic Infections / complications
  • Opportunistic Infections / microbiology*
  • Opportunistic Infections / therapy*
  • Rhinitis / etiology
  • Rhinitis / immunology
  • Rhinitis / therapy
  • Sinusitis / etiology
  • Sinusitis / immunology
  • Sinusitis / therapy
  • Staphylococcal Infections / complications
  • Staphylococcal Infections / therapy

Substances

  • Anti-Bacterial Agents